Key facts
- Excision Medical’s last known valuation is $26.0M.
- It has raised $18.2M across 5 recorded rounds; the latest was Early Stage VC ($10.9M) in Sep 2024.
- Notable investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, Boston Scientific.
- Excision Medical has filed 6 Form Ds with the SEC since 2022, most recently Nov 2024 ($10.9M sold to 57 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Excision Medical
Funding rounds
5 roundsAbout Excision Medical
Developer of a leaflet excision technology designed for the lifetime management of aortic stenosis. The company uses a leaflet modification technology to target and excise one or more aortic valve leaflets while also considering the hemodynamic needs of patients, enabling physicians to target and excise one or more aortic valve leaflets while also considering the hemodynamic needs of patients.
- Sector
- Healthcare
- HQ
- Exton, PA, United States
- Founded
- 2020
- Employees
- 10
- Website
- excisionmed.com/
- Ownership
- Privately Held (backing)
Excision Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Excision Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Excision Medical in its N-PORT filings yet. We sweep new filings monthly.